Skip to main content
OpenTrials
Completed

NCT Number: NCT00159549

Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

A parallell group study comparing the effect of an education program with an education and training program for patients with COPD. 30 participants in each group. Participants self-select which group they wanted to be in. Main outcome is SGRQ (a HQoL for patients with COPD).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Community Medicine and General Practice

Trondheim, N-7489, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with COPD (FEV1<75% of expected) who have the ability to conversation and active participation will be included.

Exclusion criteria

-

Treatment and study plan

education and training program

Behavioral

Primary outcomes

  1. St Geoprg Respiratory Questionnaire (SGRQ)

Secondary outcomes

  1. COPD-Efficacy scale (Norwegian short version), Breathing Problems Questionnaire (BPQ), journal examinations, FVC, FEV1, six minutes walking test with registration of shortness of breath and pulseoxymetrical data.

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

  • Helse Nord-Trøndelag HF

Registry information

Important dates

Study start
2000
Study completion
2005
First posted
Sep 12, 2005
Registry last updated
Nov 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.